We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Burden of Cervical Cancer in Tanzania

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01177345
Recruitment Status : Unknown
Verified September 2010 by Kilimanjaro Christian Medical Centre, Tanzania.
Recruitment status was:  Not yet recruiting
First Posted : August 9, 2010
Last Update Posted : September 6, 2010
Sponsor:
Information provided by:
Kilimanjaro Christian Medical Centre, Tanzania

Brief Summary:

Cervical cancer screening is a worldwide problem especially in the developing world of which Tanzania belongs. It is diagnosed late in the third world because there are no diagnostic facilities and resource people. It occurs in the age groups between 40 and above and therefore affects the productive age of the community. It is well known that women generally are the backbone of every community and specifically in the developing countries.

The objective of this research is to analyze and quantify the burden of cervical cancer disease in the community. It will research the interpersonal and socioeconomic issues associated with cervical cancer disease in the family.


Condition or disease
Cervical Cancer -Socioeconomic Burden of Disease

Study Type : Observational
Estimated Enrollment : 105 participants
Observational Model: Cohort
Time Perspective: Cross-Sectional
Official Title: Survey Assessment and Projection of the Social and Economic Burdens of Cervical Cancer in Tanzania
Study Start Date : October 2010
Estimated Primary Completion Date : October 2012
Estimated Study Completion Date : December 2012

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Cervical Cancer
U.S. FDA Resources

Group/Cohort
Terminal Disease
Terminal cervical cancer- not treatable
Early Disease
Early cervical cancer = meaning treatable with hysterectomy.
Advanced Disease
Advanced cervical cancer- treatable with chemotherapy and/or radiation.



Primary Outcome Measures :
  1. Socioeconomic burden to households [ Time Frame: 12 months ]
    1. share of household consumption attributable to medical care (hospitals, dispensaries, etc.)
    2. monthly household income (work hours, income sources, changes in the type or amount)
    3. child school attendance, nutrition (school days missed in past week, meals eaten, source of proteins on day prior to interview)


Secondary Outcome Measures :
  1. Projection of economic impact on community [ Time Frame: 12 months ]
    Combine rates of cervical cancer with the age and gender distribution in the Kilimanjaro Region (Tanzania Census), distribution of cancer stages, and primary outcomes from the study cohort to estimate of total medical expenses, income losses, and school days missed due to cervical cancer.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   30 Years to 75 Years   (Adult, Senior)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Women diagnosed with cervical cancer at the Reproductive Health Clinic at Kilimanjaro Christian Medical Centre (KCMC) and satellite cervical cancer screening clinics in rural areas affiliated with KCMC.
Criteria

Inclusion Criteria:

  • new pathological diagnosis of cervical cancer

Exclusion Criteria:

  • non consenting individuals

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01177345


Contacts
Contact: Olola Oneko, MMED 255 754 478 917 onekoolola@yahoo.com

Locations
Tanzania
Kilimanjaro Christian Medical Center Not yet recruiting
Moshi, Kilimanjaro Region, Tanzania
Principal Investigator: Olola Oneko, MMED         
Sponsors and Collaborators
Kilimanjaro Christian Medical Centre, Tanzania

Responsible Party: Olola Oneko, Kilimanjaro Christian Medical Centre, Tanzania
ClinicalTrials.gov Identifier: NCT01177345     History of Changes
Other Study ID Numbers: 36813
First Posted: August 9, 2010    Key Record Dates
Last Update Posted: September 6, 2010
Last Verified: September 2010

Additional relevant MeSH terms:
Uterine Cervical Neoplasms
Uterine Neoplasms
Genital Neoplasms, Female
Urogenital Neoplasms
Neoplasms by Site
Neoplasms
Uterine Cervical Diseases
Uterine Diseases
Genital Diseases, Female